Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects

ISSN： 1044-579X

Source： Seminars in Cancer Biology, Vol.10, Iss.6, 2000-12, pp. : 443-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre-clinical development of farnesyltransferase inhibitors

By Lobell R.B. Kohl N.E.

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 203-210

Springer Publishing Company

Access to resources Recommend Favorite

Development of Farnesyltransferase Inhibitors for Clinical Cancer Therapy: Focus on Hematologic Malignancies

By Karp Judith Lancet Jeffrey

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 484-494

Informa Healthcare

Access to resources Recommend Favorite

Farnesyltransferase inhibitors as radiation sensitizers

By Brunner T. B. Gupta A. K. Shi Y. Hahn S. M. Muschel R. J. McKenna W. G. Bernhard E. J.

International Journal of Radiation Biology, Vol. 79, Iss. 7, 2003-07 ,pp. : 569-576

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: A Review of Their Clinical Status as Antineoplastic Agents

By Garcia-Manero Guillermo Issa Jean-Pierre

Cancer Investigation, Vol. 23, Iss. 7, 2005-10 ,pp. : 635-642

Informa Healthcare

Access to resources Recommend Favorite

Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 3, 2005-05 ,pp. : 201-213

Bentham Science Publishers

Access to resources Recommend Favorite